Ardelyx (ARDX) Change in Account Payables (2013 - 2026)
Ardelyx (ARDX) posted Change in Account Payables of $9.0 million for Q1 2026, up 960.36% on a QoQ basis from $845000.0 in Q4 2025, and up 493.33% year-over-year from $1.5 million in Q1 2025.
Ardelyx (ARDX) Change in Account Payables (2013 - 2026) Analysis & Trends
Ardelyx's Change in Account Payables history runs 14 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- Quarterly Change in Account Payables rose 493.33% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.5 million (up 507.12% YoY) and the FY2025 annual result came in at $3.2 million, down 33.46% from the prior year.
- Change in Account Payables was $9.0 million for Q1 2026 at Ardelyx, up from $845000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $9.0 million in Q1 2026 and bottomed at -$6.4 million in Q2 2024.
- A 5-year average of $1.4 million and a median of $845000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 55228.57% — and 2023, when it sank 609.1%.
- Ardelyx's Change in Account Payables stood at $7.7 million in 2022, then sank by 56.08% to $3.4 million in 2023, then plunged by 65.43% to $1.2 million in 2024, then declined by 28.15% to $845000.0 in 2025, then jumped by 960.36% to $9.0 million in 2026.
- Business Quant data shows ARDX's Change in Account Payables at $9.0 million in Q1 2026, $845000.0 in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 8.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.96 Mn |
| Mar 31, 2026 | 8.96 Mn |
| Dec 31, 2025 | 845,000.00 |
| Dec 31, 2025 | 845,000.00 |
| Sep 30, 2025 | -3.30 Mn |
| Sep 30, 2025 | -3.30 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Jun 30, 2024 | -6.40 Mn |
| Jun 30, 2024 | -6.40 Mn |
| Mar 31, 2024 | 6.14 Mn |
| Mar 31, 2024 | 6.14 Mn |
| Dec 31, 2023 | 3.40 Mn |
| Dec 31, 2023 | 3.40 Mn |